BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6491311)

  • 1. Complement and its fractions (C3-C4) pattern in subjects with neoplasia.
    Mangano A; Messina L; Birgillito S; Stivala F; Bernardini A
    J Immunopharmacol; 1984; 6(3):147-62. PubMed ID: 6491311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 3. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complement. Evaluation of some complement fractions in patients affected by neoplasia undergoing chemotherapy (author's transl)].
    Ignesti C; Lenzi L; Salvadori D; Innocenti V; Baroncelli C; Casadei BM
    Quad Sclavo Diagn; 1981 Jun; 17(2):152-6. PubMed ID: 6943601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with carcinoma of the oral cavity, uterine cervix, and breast.
    Vijayakumar T; Ankathil R; Remani P; Beevi VM; Vijayan KK; Panicker CK
    J Clin Immunol; 1987 Jul; 7(4):300-3. PubMed ID: 3611297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of serum complement levels in cancer patients with progressing tumors.
    Verhaegen H; De Cock W; De Cree J; Verbruggen F
    Cancer; 1976 Oct; 38(4):1608-13. PubMed ID: 991081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement changes in falciparum malaria infection.
    Phanuphak P; Hanvanich M; Sakulramrung R; Moollaor P; Sitprija V; Phanthumkosol D
    Clin Exp Immunol; 1985 Mar; 59(3):571-6. PubMed ID: 3886219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of immunoglobulins and complement components in patients with recurrence after resection of gastric carcinoma.
    Janssen CW; Tønder O; Matre R
    Cancer Detect Prev; 1987; 10(3-4):303-9. PubMed ID: 3568028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation into the relationships between serum levels of C3, C4 and CH50.
    Salkie ML; Kelker DH
    Vox Sang; 1981; 41(5-6):282-6. PubMed ID: 6976657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis.
    Anil S; Beena VT; Remani P; Mysore J; Vijayakumar T
    Ann Dent; 1993; 52(1):18-20. PubMed ID: 8323245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complement behavior in rats bearing Yoshida tumors subjected to treatment with gonadotropin and PGE2].
    Mangano A; Nobile G
    Boll Soc Ital Biol Sper; 1991 Mar; 67(3):295-302. PubMed ID: 1930905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulins and complement in migraine.
    Jerzmanowski A; Klimek A
    Cephalalgia; 1983 Jun; 3(2):119-23. PubMed ID: 6871986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-related correlations between immunoglobulins and complement components in preoperative sera from patients with gastric carcinoma.
    Janssen CW; Tönder O; Matre R
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1601-5. PubMed ID: 6685643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
    Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
    Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel ELISA for the evaluation of the classical pathway of complement.
    Zwirner J; Wittig A; Kremmer E; Götze O
    J Immunol Methods; 1998 Feb; 211(1-2):183-90. PubMed ID: 9617842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of the serum levels of complement during the first year of life].
    Pedraz C; Lorente F; Pedraz MJ; Salazar Villalobos V
    An Esp Pediatr; 1980 Jul; 13(7):571-6. PubMed ID: 7416647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial changes of complement titers in the acute phase of myocardial infarction.
    Imai T; Takase S; Arai M; Fujita T
    Jpn Circ J; 1983 Mar; 47(3):289-93. PubMed ID: 6834639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of chronic generalized periodontitis. 2. Estimation of total hemolytic complement (CH 50) and its fractions C3 and C4.
    Anil S; Beena VT; Remani P; Haseenabeevi M; Vijayakumar T
    Indian J Dent Res; 1991; 2(3-4):35-9. PubMed ID: 1821159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.